The American Medical Association adopted a policy Monday opposing state and federal efforts that would limit access to evidence-based fertility care, including in vitro fertilization, warning that lawmakers are increasingly advancing nonmedical interventions that could delay effective treatment.
“Board-certified physicians who provide infertility assessment and treatment are trained to deliver comprehensive, evidence-based care that optimizes wellness, fertility, and pregnancy outcomes,” said Dr. Melissa Garretson, a member of the AMA’s Board of Trustees. “Delays in accessing effective fertility treatment can have real and lasting consequences for patients and families.”
Already a subscriber? Sign in